ALL ABOUT DAILYZ HEALTH NEWS
ALL ABOUT DAILYZ HEALTH NEWS
A study at ENDO 2026 found that type 2 diabetes patients who nap over 30 minutes have a higher risk of fatty liver disease.
Read More
Bangladesh’s measles outbreak has killed over 650 children, prompting WHO and UNICEF to launch emergency vaccinations for young children.
Read More
The FDA approved CASGEVY™, the first CRISPR gene-edited cell therapy, for severe sickle cell disease patients 12 and older with recurrent crises.
Read More
The WHO has not declared a global health emergency over the drug-resistant tuberculosis strain linked to U.S. travelers as of mid-2025.
Read More
The Biden administration announced a plan to cap insulin out-of-pocket costs at $35 monthly for all insured Americans, expanding beyond Medicare.
Read More
As of mid-2026, the FDA has not approved any gene-editing therapies for type 1 diabetes, with such treatments still in preclinical stages.
Read More
A six-month trial in NEJM found hybrid closed-loop insulin pumps improved A1c and reduced severe hypoglycemia in type 1 diabetes patients.
Read More
The FDA has not approved RebiQuent for moderate to severe atopic dermatitis; current oral treatments include abrocitinib and upadacitinib.
Read More
UnitedHealth’s Change Healthcare unit suffered a ransomware attack exposing data of 4.2 million patients; a $22 million ransom was paid.
Read More
A study finds changes in two blood proteins enable over 90% accurate early detection and monitoring of aggressive glioblastoma brain cancer.
Read More